ONY Biotech is a leading neonatology pharmaceutical company based in Buffalo, NY, dedicated to improving outcomes for premature babies and their families. Since 1998, they have been at the forefront of developing non-invasive therapies, such as Infasurf calfactant, which effectively prevents and treats respiratory distress syndrome in newborns by restoring lung surface activity and enhancing respiration.
With a strong commitment to teamwork and innovation, ONY Biotech has achieved remarkable international sales, setting new records in the industry. Their mission is to advance neonatal care and reduce newborn deaths caused by prematurity through cost-effective interventions. Through their cutting-edge research and development, they continue to illuminate the path forward in neonatology, making a significant impact on the lives of premature babies and their families.
Generated from the website